Cannabis Medical Program Qualifying Conditions in Mexico

Legal Status and Framework

Mexico amended its General Health Law (Ley General de Salud) in June 2017 to permit medical use of cannabis ^[1]. The amendment added Article 245 to allow the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to authorize therapeutic and scientific use of cannabis and cannabis-derived medicines under controlled conditions ^[1].

Mexico's approach differs from a "qualifying conditions" list model used in some U.S. jurisdictions. Instead, COFEPRIS reviews individual requests and makes case-by-case determinations based on clinical evidence and medical need ^[2]. There is no published list of automatically approved conditions. Patients and physicians must submit applications with medical documentation to COFEPRIS for evaluation Strong evidence ^[1].

Medical Conditions Addressed by COFEPRIS Authorizations

While COFEPRIS has not published a definitive qualifying conditions list, approved authorizations have been granted for conditions including: epilepsy (particularly refractory forms), multiple sclerosis, chronic pain, cancer-related symptoms, and chemotherapy-induced nausea Anecdote ^[2][3]. Epilepsy and multiple sclerosis represent the largest share of reported authorizations ^[2].

However, the fact that COFEPRIS has approved cannabis for a condition does not mean automatic approval for all patients with that diagnosis. Each request requires: a prescription from a Mexican physician, detailed medical history, documented failure of conventional treatments, and clinical justification for why cannabis is appropriate Strong evidence ^[1]. COFEPRIS reserves the right to deny requests even for conditions where prior approvals have been granted Strong evidence.

Application Process and Requirements

Patients seeking medical cannabis authorization in Mexico must follow these steps ^[1][2]:

1. Obtain a physician's recommendation: A licensed Mexican healthcare provider must evaluate the patient and determine medical cannabis is appropriate.
2. Prepare documentation: Gather medical records, diagnostic reports, and evidence that conventional treatments have been tried or are inappropriate.
3. Submit to COFEPRIS: The application is filed through the federal health system. Some applications are submitted directly to COFEPRIS; others may go through state health authorities Weak / limited ^[2].
4. Await review: COFEPRIS conducts an individual assessment. No timeline is guaranteed Anecdote ^[3].
5. Receive authorization: If approved, the patient receives written authorization specifying the form, dose, and duration of cannabis use Strong evidence ^[1].

Approvals typically specify pharmaceutical-grade cannabis products or standardized extracts rather than whole plant material Strong evidence ^[1].

Common Misconceptions

Misconception: There is a published list of qualifying conditions. Reality: COFEPRIS has not released a formal list. Eligibility is determined on a case-by-case basis Strong evidence.

Misconception: All doctors can prescribe cannabis. Reality: The prescribing physician must be licensed in Mexico and submit the prescription as part of a formal COFEPRIS authorization request. Standard prescription pads do not authorize cannabis Strong evidence ^[1].

Misconception: Recreational cannabis legality (de facto toleration in Mexico City) extends to medical access nationwide. Reality: Recreational cannabis remains illegal under federal law, though enforcement varies by state. Medical authorization is a separate, federal process requiring COFEPRIS approval Strong evidence ^[2].

Misconception: Obtaining authorization is quick and routine. Reality: Approvals can take months and are not guaranteed, even for commonly approved conditions Anecdote ^[3].

Recent Developments and Jurisdiction Notes

As of November 2024, Mexico's federal medical cannabis framework remains based on the 2017 amendment and COFEPRIS's implementing regulations ^[1]. Some Mexican states (notably Mexico City) have implemented additional local protections and have expanded local medical cannabis research programs, but federal authorization through COFEPRIS remains the pathway for legal medical cannabis access nationwide [evidence:reported] ^[3].

In October 2024, Mexico's Congress approved a broader reform to decriminalize small-scale cannabis cultivation for personal use, but this does not change COFEPRIS medical authorization requirements [evidence:reported] ^[4]. Medical users seeking legal cannabis must still obtain COFEPRIS authorization; decriminalization of personal cultivation does not create an automatic medical exception Strong evidence.

Important Note: Cannabis remains classified under international drug control treaties. Possession without authorization is illegal Strong evidence ^[1].

Legal Disclaimer

This article is for informational purposes only and is not legal advice. Laws and regulations change. COFEPRIS policies and individual authorization outcomes are subject to change without notice. The interpretation and application of Mexican cannabis law vary by jurisdiction and individual circumstance.

If you are seeking medical cannabis authorization in Mexico:

• Consult a qualified Mexican attorney with expertise in health law or cannabis regulation.
• Contact COFEPRIS directly or a licensed Mexican physician for current application procedures.
• Do not rely on this article as a substitute for professional legal counsel.

Cross-border transport of cannabis (including from Mexico to the U.S. or vice versa) is illegal under all circumstances, regardless of authorization status in either country.

Sources

How this page was made